Tomas J. Heyman - 15 Sep 2022 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
3
Filing time
16 Sep 2022, 16:50:14 UTC
Previous filing
24 Jun 2022
Next filing
25 May 2023

No securities are beneficially owned.